Delivery Order SPE2DB20D3103-SPE2DB25FN4A2
Award Date
4/10/25
Potential Completion Date
4/11/25
Potential Value
$10K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $40,185.88 firm fixed price delivery order is for the supply of 4,567,750,986 units of the drug Sorafenib 200 mg tablets. The contract has an ultimate completion date of April 1, 2025 and does not include a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Sorafenib 200 mg tablets and has a ceiling value of $9,378.30. It is a firm fixed-price contract with a completion date of May 25, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $16,253.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4564742986 - Sorafenib 200 mg Tablets in 120-count bottles, with a completion date of May 30, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division provides for the delivery of 4,564,753,052 units of Sorafenib 200 mg tablets to the U.S. government. The contract, valued at $33,960.52, is a firm fixed-price delivery order with a period of performance through May 31, 2024. It was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a major procurement arm of the Department of Defense (DoD). Amerisourcebergen, a leading pharmaceutical...
This federal contract award, SPE2DB20D3103|SPE2DB25FN1T9, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,603.82 firm fixed-price delivery order is for the supply of 4567678535 SORAFENIB 200 MG TABLET 120S. The contract has an ultimate completion date of March 25, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Sorafenib 200 mg tablets. The contract, valued at $18,759.23, is a Firm Fixed Price Delivery Order with an ultimate completion date of August 1, 2024. This award is not associated with any set-aside program. As a significant supplier of pharmaceutical products and medical supplies to the U.S. federal government, Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $56,333.26 firm-fixed-price delivery order is for the supply of Sorafenib 200 mg tablets. The contract has an ultimate completion date of May 1, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $84,773.77 firm fixed-price delivery order is for the supply of 4,558,627,779 units of Sorafenib 200 mg tablets. The contract has a completion date of September 29, 2022 and was awarded on September 28, 2022. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has been awarded several...
This federal contract award, valued at $8,736.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NEXAVAR 200 MG TABLET 120S, a pharmaceutical product, with a performance period ending on February 14, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a total potential value of...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,736.00, is for the delivery of Nexavar 200 mg tablets. The contract has a period of performance through April 16, 2025 and is a firm fixed-price arrangement. This contract award is not designated as a set-aside and represents open competition. AmerisourceBergen holds a larger...